Varun Bafna: The Power of Extended Half-Life Factor IX in Enabling Safe Major Surgeries
Varun Bafna, Hematologist, Hemato-Oncologist and BMT Physician at Dr. Bafna Star Superspeciality Clinics, shared on LinkedIn:
”A rare and rewarding clinical experience in hemophilia care.
We recently managed an 81-year-old gentleman with severe Hemophilia B (FIX <1%, inhibitor negative) — possibly among the oldest patients to successfully undergo major orthopedic surgery in this setting.
Indication: Left gleno-humeral joint osteoarthritis secondary to recurrent hemarthrosis
Procedures: Left shoulder joint replacement plus prostate surgery
With meticulous perioperative planning, we administered a single pre-operative dose of Refixia (80 IU/kg; 4000 IU) 1–2 hours prior to incision.
- Surgery was completed successfully
- No intraoperative or postoperative bleeding complications
- No additional factor dosing required
- Post-operative course remained stable
- Inhibitor screening remained negative
This case highlights the power of extended half-life Factor IX in enabling safe major surgeries with reduced dosing burden — even in elderly hemophilia patients with advanced joint disease.
A special acknowledgment to the surgical team:
- Dr. Namdev Gorgille, Shoulder Specialist, Miraj
- Dr. Naaz Namaje, Anaesthetist
Looking ahead: With emerging therapies like Concizumab, there is growing evidence supporting prophylaxis in hemophilia (including inhibitor and non-inhibitor patients) to reduce bleeding episodes and prevent long-term joint damage.
Such approaches may further improve surgical readiness and outcomes in the future.
A step forward in advancing comprehensive hemophilia care.”

Stay updated with Hemostasis Today.
-
Nov 18, 2026, 15:11Vansh Yaduvanshi: Why Compatible Blood Groups Do Not Always Mean Compatible Blood
-
Nov 18, 2026, 14:49Estetrol-Based Contraception in PCOS and Its Effects on Coagulation – RPTH Journal
-
Nov 18, 2026, 14:41Factor V Deficiency: Diagnostic Challenges and the Role of Combined Factor V and VIII Deficiency
-
Nov 18, 2026, 14:29Maxime Dely: When Patient Encounters Become Life Lessons
-
Nov 18, 2026, 14:23Basanta Khatiwada: Advancing Haematology Through Research and Innovation at HAEMATOCON 2026
-
Nov 18, 2026, 14:13Alvin Katumba: Sickle Cell Disease Research Recognised With a 2026 ASH Abstract Achievement Award
-
Nov 18, 2026, 13:34Vincenzo De Angelis: Strengthening Plasma Management and Quality Control in Eastern Europe
-
Nov 18, 2026, 13:34Standardizing Bleeding Outcome Assessment in Hemophilia Clinical Trials – JTH
-
Nov 18, 2026, 13:34Nicolas Gendron: The Ecological Transition in Thrombosis and Haemostasis